Welcome back, everyone. We hope the weekend was pleasant and relaxing. Now, of course, the routine returns and so we are brewing another cup of stimulation to jumpstart the process. Good luck with those meetings and deadlines, and stay in touch...
FDA To Review Glaxo Rotarix Vaccine On May 7 (Dow Jones)
Novartis And Roche Threaten To Leave The UK (The Guardian)
Nycomed Still Plans An IPO (Wall Street Journal)
Lilly Is Downsizing In Indianapolis (Indianapolis Star)
Quebec May Sue Pharma Over Ontario Pricing Deal (The Globe & Mail)
Coffee pix thx to chichcacha flickr creative commons
1 Comment
Timing seems just about right for Novartis and Roche to play hardball with the UK - this is really over NICE - i think we all get it.
So, let's figure this out, do we save 3,500 jobs but see drug price increases that will in the long term cost way higher than keeping the 3,500 jobs?
Where will all those jobs go? Will this actually break the back of the UK economy?
More than likely some other industry will fill the gap.
Perhaps those 3,500 jobs will go into businesses that help prevent diseases rather than trying to close the barn door after the horse is already out - just a thought...